London, United Kingdom · Founded 2019 · Privately Held (backing)
Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. Tenpoint Therapeutics is based in London, United Kingdom and was founded in 2019. Its last reported valuation was $76.6 million in Jul 2023. It has raised $312 million.
Last reported valuation
$76.6M
Oct 2026
Priced at
—
Total raised
$312.1M
Last round
—
Cap table — not yet on record
Tenpoint Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tenpoint Therapeutics with a free account
·The complete investor list: 15 names
·Watch Tenpoint Therapeutics: the Monday email on marks, rounds and moves
